Course Descriptor
Cell Therapy is a term used to describe therapies whereby living cells are introduced into a patient to achieve a therapeutic benefit. In Europe, they fall under the category of ATMPs and, depending on how they are modified, some may be approved as ex vivo gene therapies (e.g. CAR-T).
This course will provide an overview of the different classes of cell and cell-based therapies including Mesenchymal Stem/Stromal Cell Therapies, Pluripotent Stem Cell Therapies, CART-T Cell Therapies, CAR-NK Cell Therapies, as well as other types of Cellular Immunotherapy.
In addition to the theoretical content concerning biology, mechanism of action, manufacturing methods, and quality control for these therapies, much time will be given to hands-on practice of techniques and operation of equipment used to produce these therapies commercially. This hands-on practical training will use state-of-the-art automated systems to showcase the current and potential future manufacturing techniques available.
Course Delivery Method:
- Two and a half days onsite at NIBRT
Course Costs:
- Full Course Two and a half days onsite at NIBRT: €2375
Course Dates:
- Full course – 06 – 08 December 2023
Introduction to Cell therapy
€2,375.00
Dates:
- 06/12/2023 - 08/12/2023
6 Places Remaining
Fee:
€2375Suitable for:
This course is ideal for anyone with an existing knowledge of biopharmaceutical processes and is looking to increase their knowledge of the expanding areas of cell and cell-based therapies.
Downloads:
For further informationWho should attend
This course is ideal for anyone with an existing knowledge of biopharmaceutical processes and is looking to increase their knowledge of the expanding areas of cell and cell-based therapies.
Key topics covered
Assessment